Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for up to 5 Oligometastases: Preliminary Results of the SABR-5 Trial

被引：0
|
作者：
Olson, R. A. [1 ,2 ]
Jiang, W. [1 ,2 ]
Liu, M. C. [1 ,3 ]
Bergman, A. [3 ]
Schellenberg, D. [1 ,4 ]
Mou, B. [1 ,5 ]
Alexander, A. S. [1 ,6 ]
Carolan, H. [1 ,3 ]
Hsu, F. [1 ,7 ]
Miller, S. [1 ,2 ]
Atrchian, S. [8 ]
Chan, E. K. [1 ,3 ]
Ho, C. [1 ,9 ]
Mohamed, I. G. [1 ,5 ]
Lin, A. [1 ,5 ]
Berrang, T. [1 ,6 ]
Bang, A. [1 ,3 ]
Chng, N. [2 ]
Matthews, Q. [2 ]
Huang, V. [4 ]
Mestrovic, T. [6 ]
Hyde, D.
Lund, C. R. [1 ,4 ]
Pai, H. H. [1 ,6 ]
Valev, B. [1 ,6 ]
Lefresne, S. [10 ,11 ]
Tyldesley, S. [1 ,3 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
[2] BC Canc Prince George, Prince George, BC, Canada
[3] BC Canc Vancouver, Vancouver, BC, Canada
[4] BC Canc Surrey, Surrey, BC, Canada
[5] BC Canc Kelowna, Kelowna, BC, Canada
[6] BC Canc Victoria, Victoria, BC, Canada
[7] BC Canc Abbotsford, Abbotsford, BC, Canada
[8] BC Canc Agcy, Radiat Oncol, Kelowna, BC, Canada
[9] BC Canc Fraser Valley, Surrey, BC, Canada
[10] BC Canc Agcy, Vancouver, BC, Canada
[11] Univ British Columbia, Dept Surg, Div Radiat Oncol, Vancouver, BC, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] POPULATION BASED PHASE II TRIAL OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR UP TO FIVE OLIGOMETASTASES: PRELIMINARY RESULTS OF THE SABR-5 TRIAL
    Olson, Robert
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah
    Schellenberg, Devin
    Mou, Benjamin
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Mestrovic, Ante
    Hyde, Derek
    Huang, Vicky
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresne, Shilo
    Tyldesley, Scott
    RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S4 - S4
  • [2] Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
    Robert Olson
    Mitchell Liu
    Alanah Bergman
    Sonya Lam
    Fred Hsu
    Benjamin Mou
    Tanya Berrang
    Ante Mestrovic
    Nick Chng
    Derek Hyde
    Quinn Matthews
    Chad Lund
    Daniel Glick
    Howard Pai
    Parminder Basran
    Hannah Carolan
    Boris Valev
    Shilo Lefresene
    Scott Tyldesley
    Devin Schellenberg
    BMC Cancer, 18
  • [3] Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
    Olson, Robert
    Liu, Mitchell
    Bergman, Alanah
    Lam, Sonya
    Hsu, Fred
    Mou, Benjamin
    Berrang, Tanya
    Mestrovic, Ante
    Chng, Nick
    Hyde, Derek
    Matthews, Quinn
    Lund, Chad
    Glick, Daniel
    Pai, Howard
    Basran, Parminder
    Carolan, Hannah
    Valev, Boris
    Lefresene, Shilo
    Tyldesley, Scott
    Schellenberg, Devin
    BMC CANCER, 2018, 18
  • [4] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
    Jiang, W. N.
    Baker, S.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Chan, E. K.
    Mohamed, I. G.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Lefresne, S.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S147 - S148
  • [5] Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5
    Olson, R.
    Liu, M.
    Bergman, A.
    Lam, S.
    Hsu, F.
    Mou, B.
    Berrang, T.
    Mestrovic, A.
    Chng, N.
    Hyde, D.
    Matthews, Q.
    Lund, C.
    Glick, D.
    Pai, H.
    Basran, P.
    Carolan, H.
    Valev, B.
    Tyldesley, S.
    Schellenberg, D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S871 - S871
  • [6] Predictors of Early Polymetastatic Relapse Following Stereotactic Ablative Radiotherapy for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial
    Baker, S.
    Mou, B.
    Jiang, W.
    Liu, M. C.
    Bergman, A.
    Schellenberg, D.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Tyldesley, S. K.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S32 - S32
  • [7] PREDICTORS OF EARLY POLYMETASTATIC RELAPSE FOLLOWING STEREOTACTIC ABLATIVE RADIOTHERAPY FOR UP TO 5 OLIGOMETASTASES: A SECONDARY ANALYSIS OF THE PHASE II SABR-5 TRIAL
    Baker, Sarah
    Mou, Benjamin
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah
    Schellenberg, Devin
    Alexander, Abraham
    Carolan, Hannah
    Atrchian, Siavash
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Tyldesley, Scott
    Olson, Robert
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S30 - S30
  • [8] PROSPECTIVE LONGITUDINAL ASSESSMENT OF QUALITY OF LIFE AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTASES: ANALYSIS OF THE POPULATION-BASED SABR-5 PHASE II TRIAL
    Cruz-Lim, Ella Mae
    Mou, Benjamin
    Baker, Sarah
    Arbour, Gregory
    Stefanyk, Kelsey
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah
    Schellenberg, Devin
    Alexander, Abraham
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Huang, Vicky
    Mestrovic, Ante
    Hyde, Derek
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresne, Shilo
    Tyldesley, Scott
    Olson, Robert
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S17 - S17
  • [9] Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial
    Cruz-Lim, E. M.
    Mou, B.
    Baker, S.
    Arbour, G.
    Stefanyk, K.
    Jiang, W.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Alexander, A. S.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E224 - E225
  • [10] Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial
    Olson, Robert
    Jiang, Will
    Liu, Mitchell
    Bergman, Alanah
    Schellenberg, Devin
    Mou, Benjamin
    Alexander, Abraham
    Carolan, Hannah
    Hsu, Fred
    Miller, Stacy
    Atrchian, Siavash
    Chan, Elisa
    Ho, Clement
    Mohamed, Islam
    Lin, Angela
    Berrang, Tanya
    Bang, Andrew
    Chng, Nick
    Matthews, Quinn
    Baker, Sarah
    Huang, Vicky
    Mestrovic, Ante
    Hyde, Derek
    Lund, Chad
    Pai, Howard
    Valev, Boris
    Lefresene, Shilo
    Tyldesley, Scott
    JAMA ONCOLOGY, 2022, 8 (11) : 1644 - 1650
12345